The role of MeCP2 in CNS development and function
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Rett syndrome is a neurodevelopmental disorder that is a direct consequence of functional mutations in the methyl-CpG-binding protein-2 (MeCP2) gene, which has focused attention on epigenetic mechanisms in neurons. MeCP2 is widely believed to be a transcriptional repressor although it may have additional functions in the CNS. Genetic mouse models that compromise MeCP2 function demonstrate that homeostatic regulation of MeCP2 is necessary for normal CNS functioning. Recent work has also demonstrated that MeCP2 plays an important role in mediating synaptic transmission in the CNS in particular, spontaneous neurotransmission and short-term synaptic plasticity. This review will discuss the role of MeCP2 in CNS development and function, as well as a potential important role for MeCP2 and epigenetic processes involved in mediating transcriptional repression in Rett syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MeCP2, a Key Contributor to Neurological Disease, Activates and Represses Transcription
Chahrour, M., Jung, S. Y., Shaw, C., Zhou, X., Wong, S. T. C., Qin, J., & Zoghbi, H. Y. (2008) · Science · doi:10.1126/science.1153252 · Cited by 1,823
A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome
Guy, J., Hendrich, B., Holmes, M., Martin, J. E., & Bird, A. (2001) · Nature Genetics · doi:10.1038/85899 · Cited by 1,558
DNA Methylation-Related Chromatin Remodeling in Activity-Dependent Bdnf Gene Regulation
Martinowich, K., Hattori, D., Wu, H., Fouse, S., He, F., Hu, Y., Fan, G., & Sun, Y. E. (2003) · Science · doi:10.1126/science.1090842 · Cited by 1,405 · cited 1×
“Most of these mutations occur de novo and are predicted to result in a loss of function of the MeCP2 protein (Matijevic et al., 2009).”
BackgroundDeficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice
Chen, R. Z., Akbarian, S., Tudor, M., & Jaenisch, R. (2001) · Nature Genetics · doi:10.1038/85906 · Cited by 1,275 · cited 4×
“To test this theory, postmitotic deletion of MeCP2 in broad forebrain regions using calcium-calmodulin-dependent protein kinase II mice produced phenotypes comparable to MeCP2 null mice but with a later onset (Chen et al., 2001).”
BackgroundMethodInfluentialDerepression of BDNF Transcription Involves Calcium-Dependent Phosphorylation of MeCP2
Chen, W. G., Chang, Q., Lin, Y., Meissner, A., West, A. E., Griffith, E. C., Jaenisch, R., & Greenberg, M. E. (2003) · Science · doi:10.1126/science.1086446 · Cited by 1,232
Reversal of Neurological Defects in a Mouse Model of Rett Syndrome
Guy, J., Gan, J., Selfridge, J., Cobb, S., & Bird, A. (2007) · Science · doi:10.1126/science.1138389 · Cited by 1,230
Zhou, Z., Hong, E. J., Cohen, S., Zhao, W.-N., Ho, H.-Y. H., Schmidt, L., Chen, W. G., Lin, Y., Savner, E., Griffith, E. C., et al. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.037 · Cited by 877 · cited 2×
“Overexpression of MeCP2 in hippocampal neurons also results in significant decreases in dendritic branching (Zhou et al., 2006).”
BackgroundNeuronal MeCP2 Is Expressed at Near Histone-Octamer Levels and Globally Alters the Chromatin State
Skene, P. J., Illingworth, R. S., Webb, S., Kerr, A. R. W., James, K. D., Turner, D. J., Andrews, R., & Bird, A. P. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.01.030 · Cited by 688 · cited 1×
“MeCP2deficient neurons also have fewer dendritic spines and reduced arborization in the hippocampus and exhibit additional impairments in neuronal maturation in both the hippocampus and in the olfactory system (Palmer et al., 2008; Smrt et al., 2007; Zhou et al., 2006).”
BackgroundDani, V. S., Chang, Q., Maffei, A., Turrigiano, G. G., Jaenisch, R., & Nelson, S. B. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506071102 · Cited by 639 · cited 1×
“Spontaneous excitatory activity in cortical pyramidal neurons is also decreased, while inhibitory activity is increased in MeCP2-mutant mice (Dani et al., 2005).”
BackgroundMild overexpression of MeCP2 causes a progressive neurological disorder in mice
Collins, A. L., Levenson, J. M., Vilaythong, A. P., Richman, R., Armstrong, D. L., Noebels, J. L., David Sweatt, J., & Zoghbi, H. Y. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh282 · Cited by 626
Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice
Tropea, D., Giacometti, E., Wilson, N. R., Beard, C., McCurry, C., Fu, D. D., Flannery, R., Jaenisch, R., & Sur, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812394106 · Cited by 593 · cited 2×
“, might also prove to be an effective strategy in mitigating the debilitating effects of RTT. Systemic treatment with growth factors, such as BDNF or IGF, may also be promising for alleviating many of the core symptoms of RTT (Chang et al., 2006; Tropea et al., 2009).”
BackgroundThe disease progression of Mecp2 mutant mice is affected by the level of BDNF expression
Chang, Q., Khare, G., Dani, V., Nelson, S., & Jaenisch, R. (2006) · Neuron · doi:10.1016/j.neuron.2005.12.027 · Cited by 578
Learning and Memory and Synaptic Plasticity Are Impaired in a Mouse Model of Rett Syndrome
Moretti, P., Levenson, J. M., Battaglia, F., Atkinson, R., Teague, R., Antalffy, B., Armstrong, D., Arancio, O., Sweatt, J. D., & Zoghbi, H. Y. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2623-05.2006 · Cited by 545
MeCP2 Controls Excitatory Synaptic Strength by Regulating Glutamatergic Synapse Number
Chao, H.-T., Zoghbi, H. Y., & Rosenmund, C. (2007) · Neuron · doi:10.1016/j.neuron.2007.08.018 · Cited by 511
Young, J. I., Hong, E. P., Castle, J. C., Crespo-Barreto, J., Bowman, A. B., Rose, M. F., Kang, D., Richman, R., Johnson, J. M., Berget, S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507856102 · Cited by 484
Kishi, N., & Macklis, J. D. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2004.07.006 · Cited by 445 · cited 1×
“Pyramidal neurons in the cortex of MeCP2 null mice have smaller somas and reduced dendritic arborization (Kishi and Macklis, 2004).”
BackgroundBelichenko, P. V., Wright, E. E., Belichenko, N. P., Masliah, E., Li, H. H., Mobley, W. C., & Francke, U. (2009) · Journal of Comparative Neurology · doi:10.1002/cne.22009 · Cited by 272
Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2
Giacometti, E., Luikenhuis, S., Beard, C., & Jaenisch, R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610593104 · Cited by 271 · cited 2×
“Two other studies demonstrated that postmitotic neuron-specific MeCP2 restoration rescues the RTT-like phenotypes observed in MeCP2-deficient mice (Giacometti et al., 2007; Luikenhuis et al., 2004).”
BackgroundMecp2 deficiency leads to delayed maturation and altered gene expression in hippocampal neurons
Smrt, R. D., Eaves-Egenes, J., Barkho, B. Z., Santistevan, N. J., Zhao, C., Aimone, J. B., Gage, F. H., & Zhao, X. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.04.005 · Cited by 239 · cited 1×
“MeCP2deficient neurons also have fewer dendritic spines and reduced arborization in the hippocampus and exhibit additional impairments in neuronal maturation in both the hippocampus and in the olfactory system (Palmer et al., 2008; Smrt et al., 2007; Zhou et al., 2006).”
BackgroundThe methyl-CpG binding protein MeCP2 is essential for embryonic development in the mouse
Tate, P., Skarnes, W., & Bird, A. (1996) · Nature Genetics · doi:10.1038/ng0296-205 · Cited by 231
Fukuda, T., Itoh, M., Ichikawa, T., Washiyama, K., & Goto, Y.-I. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.6.537 · Cited by 221
Kondo, M., Gray, L. J., Pelka, G. J., Christodoulou, J., Tam, P. P. L., & Hannan, A. J. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06305.x · Cited by 190
Samaco, R. C. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh063 · Cited by 163 · cited 2×
“…with Angelman syndrome (Watson et al., 2001), non-syndromic mental retardation (Miltenberger-Miltenyi and Laccone, 2003), Prader–Willi syndrome (Samaco et al., 2004), and some forms of autism (Shibayama et al., 2004) have mutations in the MeCP2 gene that significantly reduce MeCP2 protein…”
BackgroundArmstrong, D. D., Dunn, K., & Antalffy, B. (1998) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199811000-00003 · Cited by 137 · cited 2×
“In female RTT patients, CA1 pyramidal neurons exhibit decreased dendritic spine density (Chapleau et al., 2010), and substantial decreases in dendritic arborization can be seen in the frontal, limbic, and motor cortices (Armstrong et al., 1998).”
BackgroundDendritic and histochemical development and ageing in patients with Down's syndrome
TAKASHIMA, S., IIDA, K., MITO, T., & ARIMA, M. (1994) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.1994.tb00394.x · Cited by 126
Cohen, D. R. S., Matarazzo, V., Palmer, A. M., Tu, Y., Jeon, O. K.-H., Pevsner, J., & Ronnett, G. V. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/s1044-7431(03)00026-5 · Cited by 119
Cited by
MicroRNAs in Neurodegenerative Diseases
(2017) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2017.04.002 · Cited by 168
MicroRNA-132, -134, and -138: a microRNA troika rules in neuronal dendrites
Bicker, S., Lackinger, M., Weiß, K., & Schratt, G. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1671-7 · Cited by 102
Neonatal MeCP2 is important for the organization of sex differences in vasopressin expression
Forbes-Lorman, R. M., Rautio, J. J., Kurian, J. R., Auger, A. P., & Auger, C. J. (2012) · Epigenetics · doi:10.4161/epi.7.3.19265 · Cited by 43
Metadata
- Authors
- Na, E. S., & Monteggia, L. M.
- Venue
- Hormones and Behavior
- Publisher
- Elsevier BV
- Published
- 2011-03
- Volume
- 59
- Issue
- 3
- Pages
- 364-368
- ISSN
- 0018-506X (ISSN-L)
- OpenAlex
- W2064977733
- Cited by
- 65
- References
- 26
- FWCI
- 3.35
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.